High-yielding dividend growth stocks are seeing more interest as some money rotates out of tech. AbbVie (ABBV) is yielding 3.2%. They are a Dividend King with 50 years of increases. Market worries about Humira facing generic competition seem mitigated by their new immunology drugs Skyrizi and Rinvoq. Procter & Gamble (PG) yields 3%. The stock is currently trading below its 5-year averages for price-to-sales, price-to-earnings, and price-to-book ratios. Enterprise Products Partners (EPD) has a 5.5% yield. They operate energy pipelines and charge a toll, so they rely on volume moved rather than the actual price of oil and gas. Payouts have increased every year since their IPO 27 years ago.